|
Pakistan 2009
(n=109 ) |
Partin 2007*
(n= 5730 ) |
CLINICAL STAGE |
|
|
T1c |
33 (30) |
4419 (77) |
T2a |
25 (23) |
998(17) |
T2b/T2c |
51 (47) |
313 (6) |
PSA (ng/ml) Δ |
|
|
0-2.5 |
3 (3) |
452 (8) |
2.6-4.0 |
2 (2) |
946 (17) |
4.1-6.0 |
15 (14) |
1994 (35) |
6.1-10.0 |
34 (31) |
1671 (29) |
>10.0 |
55 ( 50) |
667 (12) |
BIOPSY GLEASON SUM |
|
|
5-6 |
63 (58) |
4402 (77) |
3+4=7 |
23 (21) |
816 (14) |
4+3=7 |
11 (10) |
348 (6) |
8-10 |
12 ( 11) |
164 (3) |
PATHOLOGICAL STAGE |
|
|
Organ confined |
63 (58) |
4204 (73) |
Extra prostatic extension |
9 (8) |
1276 (22) |
Seminal vesicle involvement |
24 (22) |
180 (3) |
Lymph node metastasis |
13 (12) |
70 (1) |
* Makarov et al. [13]
Δ Abbot Hybritech Assay |